ClinicalMetric tracks all active clinical trials for cbd sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 1 1
Top Sponsors
1 trial
1 trial
Recruiting Clinical Trials
NCT07001930 Phase 1
Recruiting
Effects of Cannabidiol on Stress and Nicotine Withdrawal
Enrollment
90 pts
Location
United States
Sponsor
Johns Hopkins University
NCT07069478
Recruiting
Cannabidiol (CBD) and Stress Response: Psychobiological Mechanisms
Enrollment
125 pts
Location
United States
Sponsor
University of Minnesota
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology